Trial
NCT01921985
Terlipressin Administration in Patients Undergoing Major Liver Resection
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
—
Condition
Liver Resection
Intervention
Terlipressin
Why stopped
Interim analysis revealed that no statistical difference will be identified after inclusion of the patient cohort as foreseen in the sample size calculation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-29